| Annie Searcy, MS CCC-SLP | |
|
3525 E Louise Dr, Suite 255, Meridian, ID 83642-6302 | |
| (208) 489-5099 | |
| (208) 489-5098 |
| Full Name | Annie Searcy |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3525 E Louise Dr, Meridian, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215375449 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP-1892 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Annie Searcy, MS CCC-SLP 3525 E Louise Dr, Suite 255, Meridian, ID 83642-6302 Ph: (208) 489-5099 | Annie Searcy, MS CCC-SLP 3525 E Louise Dr, Suite 255, Meridian, ID 83642-6302 Ph: (208) 489-5099 |
News Archive
Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, and Angsana Molecular & Diagnostics Laboratory Pte Ltd, a subsidiary of Parkway Pantai, announce a partnership to market the MammaPrint Breast Cancer Risk of Recurrence test and the BluePrint Molecular Subtyping test to physicians across Southeast Asia, including Singapore, Malaysia, Vietnam, Brunei and Myanmar.
Although type 1 diabetes can be controlled with insulin injections and lifestyle modifications, major advances in treating the disease have not been made in more than two decades and there remain fundamental gaps in what is understood about its causes and how to halt its progression.
Researchers have discovered a new compound that restores the health of mice infected with methicillin-resistant Staphylococcus aureus (MRSA), an otherwise dangerous bacterial infection. The new compound targets an enzyme not found in human cells but which is essential to bacterial survival.
According to a new study from researchers at the Cornell University, obesity can actually dull the taste buds as has been suspected for a long time. The study appeared in the latest issue of the journal PLoS Biology yesterday (20th of March 2018).
Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug.
› Verified 6 days ago
Mrs. Noel Q. Hurst, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1550 N Crestmont Dr, Meridian, ID 83642 Phone: 208-898-0988 | |
Hannah Bragg, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1857 S Millenium Way Ste 120, Meridian, ID 83642 Phone: 208-600-0722 Fax: 208-620-2134 | |
Ms. Anne Marie Kuhlmeier, SLP/CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3525 E Louise Dr, Suite 255, Meridian, ID 83642 Phone: 208-489-5099 Fax: 208-489-5077 | |
Mrs. Amy Patricia Morehead, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1550 N Crestmont Dr Ste E, Meridian, ID 83642 Phone: 208-898-0988 Fax: 208-898-9022 | |
Alexandria Darlene Rupp, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1833 Millenium Way Ste 100, Meridian, ID 83642 Phone: 208-284-4672 | |
Catherine Danielle Olaso, Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 68 S Baltic Pl, Meridian, ID 83642 Phone: 208-898-0988 | |
First Words Speech Therapy Services, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2488 E Green Canyon Dr, Meridian, ID 83642 Phone: 208-761-6341 Fax: 208-846-8966 |